Spontaneous and granulocyte–colony-stimulating factor-enhanced marrow response and progenitor cell mobilization in mice after myocardial infarction
- PMID: 20230223
- DOI: 10.3109/14653240903580262
Spontaneous and granulocyte–colony-stimulating factor-enhanced marrow response and progenitor cell mobilization in mice after myocardial infarction
Abstract
Background aims: Hematopoietic (HPC), mesenchymal (MPC) and/or endothelial (EPC) progenitor cells are being studied to repair the myocardium after acute or chronic ischemia. We examined marrow response to myocardial infarction (MI) and the ability of granulocyte–colony-stimulating factor (G-CSF) to enhance mobilization of HPC, MPC and EPC in peripheral blood (PB) and bone marrow (BM) of MI mice.
Methods: We induced MI in C57Bl/6 mice, while sham-operated (SO) animals were similarly operated on but without coronary artery ligation. Animals were treated with either saline or G-CSF, from day −5 to day +5 after MI or from day 0 to day +5. Progenitor cell numbers in PB and BM were evaluated by fluorescence-activated cell sorting (FACS) analysis and cell culture.
Results: White blood cells (WBC) decreased in BM and increased in PB after MI; G-CSF amplified this effect in BM but not in PB. HPC numbers decreased in BM after MI, while HPC and granulocyte–macrophage colony-forming units (GM-CFU) increased in PB only after G-CSF treatment, and more prominently so in MI than in SO mice. MPC and fibroblast–colony-forming units (F-CFU) as well as EPC were mobilized into the PB after MI and further after G-CSF treatment. Plasma troponin T concentrations decreased after G-CSF treatment.
Conclusions: BM is globally affected by acute MI, but not simple body injury, with intense mobilization of marrow MPC and EPC into the PB but inhibition of HPC. Progenitor cell entry into the PB may be paralleled by depletion of their BM pools. G-CSF is required for HPC mobilization and enhances MPC and EPC entry into the PB.
Similar articles
-
Effects of granulocyte-colony-stimulating factor on progenitor cell mobilization and heart perfusion and function in normal mice.Cytotherapy. 2011 Feb;13(2):237-47. doi: 10.3109/14653249.2010.491820. Epub 2010 Jun 4. Cytotherapy. 2011. PMID: 20524771
-
The effects of age, disease state, and granulocyte colony-stimulating factor on progenitor cell count and function in patients undergoing cell therapy for cardiac disease.Stem Cells Dev. 2013 Jan 15;22(2):216-23. doi: 10.1089/scd.2012.0139. Epub 2012 Sep 7. Stem Cells Dev. 2013. PMID: 22834565 Clinical Trial.
-
A novel anti-inflammatory function of human galectin-1: inhibition of hematopoietic progenitor cell mobilization.Exp Hematol. 2007 Feb;35(2):305-13. doi: 10.1016/j.exphem.2006.09.015. Exp Hematol. 2007. PMID: 17258079
-
Pleiotropic effects of cytokines on acute myocardial infarction: G-CSF as a novel therapy for acute myocardial infarction.Curr Pharm Des. 2003;9(14):1121-7. doi: 10.2174/1381612033455008. Curr Pharm Des. 2003. PMID: 12769752 Review.
-
Mechanisms of granulocyte colony-stimulating factor-induced hematopoietic progenitor-cell mobilization.Semin Hematol. 2000 Jan;37(1 Suppl 2):25-32. doi: 10.1016/s0037-1963(00)90086-6. Semin Hematol. 2000. PMID: 10718156 Review.
Cited by
-
Quo Vadis? Immunodynamics of Myeloid Cells after Myocardial Infarction.Int J Mol Sci. 2022 Dec 13;23(24):15814. doi: 10.3390/ijms232415814. Int J Mol Sci. 2022. PMID: 36555456 Free PMC article. Review.
-
Administration of granulocyte-colony stimulating factor accompanied with a balanced diet improves cardiac function alterations induced by high fat diet in mice.BMC Cardiovasc Disord. 2015 Dec 3;15:162. doi: 10.1186/s12872-015-0154-6. BMC Cardiovasc Disord. 2015. PMID: 26631050 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical